Ticker: MRZM

Marizyme, Inc. (PINK: MRZM) has recently reported its Q3 2024 financial results, showcasing significant challenges and opportunities for the company. While DuraGraft has received FDA clearance, which marks a potential turning point, the financials indicate ongoing difficulties. Key Financial High...